Suppr超能文献

皮肤利什曼病的消退:白细胞介素12引发保护性1型辅助性T细胞免疫反应。

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.

作者信息

Sypek J P, Chung C L, Mayor S E, Subramanyam J M, Goldman S J, Sieburth D S, Wolf S F, Schaub R G

机构信息

Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.

出版信息

J Exp Med. 1993 Jun 1;177(6):1797-802. doi: 10.1084/jem.177.6.1797.

Abstract

Resistance to Leishmania major in mice is associated with the appearance of distinct T helper type 1 (Th1) and Th2 subsets. T cells from lymph nodes draining cutaneous lesions of resistant mice are primarily interferon gamma (IFN-gamma)-producing Th1 cells. In contrast, T cells from susceptible mice are principally Th2 cells that generate interleukin 4 (IL-4). Although existing evidence is supportive of a role for IFN-gamma in the generation of Th1 cells, additional factors may be required for a protective response to be maintained. A potential candidate is IL-12, a heterodimeric cytokine produced by monocytes and B cells that has multiple effects on T and natural killer cell function, including inducing IFN-gamma production. Using an experimental leishmanial model we have observed that daily intraperitoneal administration at the time of parasite challenge of either 0.33 micrograms IL-12 (a consecutive 5 d/wk for 5 wk) or 1.0 micrograms IL-12 per mouse (only a consecutive 5 d) caused a > 75% reduction in parasite burden at the site of infection, in highly susceptible BALB/c mice. Delay of treatment by 1 wk had less of a protective effect. Concomitant with these protective effects was an increase in IFN-gamma and a decrease in IL-4 production, as measured by enzyme-linked immunosorbent assay of supernatants generated from popliteal lymph node cells stimulated with leishmanial antigen in vitro. The reduction in parasite numbers induced by IL-12 therapy was still apparent at 10 wk postinfection. In addition, we observed that the administration of a rabbit anti-recombinant murine IL-12 polyclonal antibody (200 micrograms i.p. every other day for 25 d) at the time of infection to resistant C57Bl/6 mice exacerbated disease. These effects were accompanied by a shift in IFN-gamma production in vitro by antigen-stimulated lymph node cells indicative of a Th2-like response. These findings suggest that IL-12 has an important role in initiating a Th1 response and protective immunity.

摘要

小鼠对硕大利什曼原虫的抗性与不同的1型辅助性T细胞(Th1)和2型辅助性T细胞(Th2)亚群的出现有关。来自抗性小鼠皮肤损伤引流淋巴结的T细胞主要是产生干扰素γ(IFN-γ)的Th1细胞。相比之下,来自易感小鼠的T细胞主要是产生白细胞介素4(IL-4)的Th2细胞。尽管现有证据支持IFN-γ在Th1细胞生成中起作用,但维持保护性反应可能还需要其他因素。一个潜在的候选因子是IL-12,它是一种由单核细胞和B细胞产生的异二聚体细胞因子,对T细胞和自然杀伤细胞功能有多种作用,包括诱导IFN-γ的产生。使用实验性利什曼原虫模型,我们观察到在寄生虫攻击时,对高度易感的BALB/c小鼠每天腹腔注射0.33微克IL-12(连续5天/周,共5周)或每只小鼠1.0微克IL-12(仅连续5天),可使感染部位的寄生虫负荷减少>75%。治疗延迟1周,保护作用减弱。与这些保护作用相伴的是,通过酶联免疫吸附测定法检测体外利什曼原虫抗原刺激的腘窝淋巴结细胞产生的上清液,发现IFN-γ增加,IL-4产生减少。IL-12治疗诱导的寄生虫数量减少在感染后10周时仍然明显。此外,我们观察到在感染时给抗性C57Bl/6小鼠注射兔抗重组鼠IL-12多克隆抗体(每2天腹腔注射200微克,共25天)会加重疾病。这些效应伴随着抗原刺激的淋巴结细胞体外IFN-γ产生的转变,表明出现了类似Th2的反应。这些发现表明IL-12在启动Th1反应和保护性免疫中起重要作用。

相似文献

引用本文的文献

7
Potential biomarkers of immune protection in human leishmaniasis.人体利什曼病免疫保护的潜在生物标志物。
Med Microbiol Immunol. 2021 Jun;210(2-3):81-100. doi: 10.1007/s00430-021-00703-8. Epub 2021 May 2.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验